Saturday, July 25, 2026
RSS

Markets & Money

US Treasury Yields Rise Amid Global Tensions: What Investors Need to Know

The 10-year US Treasury yield has risen to 4.558%, prompting concerns about borrowing costs and potential impacts on the economy.

By Catherine Walsh • July 20, 2026
Markets & Money

Canada's CPI Decline: Implications for the Bank of Canada and Investors

Canada's June CPI shows a year-over-year increase of 2.8%, raising questions about future Bank of Canada rate decisions.

Tyler Brooks • Jul 20
Energy

Magnolia Oil & Gas Expands its Footprint with $4B WildFire Energy Acquisition

Magnolia Oil & Gas announces a $4 billion acquisition of WildFire Energy, impacting its operations and dividends amid rising oil prices.

Diana Kowalski • Jul 20
Trade with the conviction of the 1%.

Institutional-grade market intelligence delivered before the opening bell.

By subscribing, I agree to receive marketing emails and alerts. View our Privacy Policy. You may unsubscribe at any time.

More Stories
Markets & Money

Brookfield and CPP Investments' $5.2B Acquisition of LXP: A New Era for Industrial REITs

Brookfield and CPP Investments' acquisition of LXP marks a significant shift in industrial real estate, promising new dy…

Marcus Rivera • Jul 20, 2026
Pharmaceutical

Standard BioTools and Treeline Biosciences: A Merger with Potential Impact

Analyzing the merger between Standard BioTools and Treeline Biosciences, highlighting financial strength and market cata…

Sarah Chen • Jul 20, 2026
Pharmaceutical

Tempus AI's Strategic Acquisition of Personalis: What It Means for Precision Oncology

Tempus AI's acquisition of Personalis enhances its precision oncology platform, signaling a shift in AI-driven diagnosti…

James McAllister • Jul 20, 2026
Pharmaceutical

Personalis Draws Merck's Takeover Interest: Implications for the Genomics Sector

Merck's interest in Personalis could signal new waves in the genomics market, stirring M&A speculations.

Marcus Rivera • Jul 17, 2026
Pharmaceutical

Sanofi's Sarclisa Escena: Innovating Cancer Treatment Delivery

Sanofi's FDA-approved Sarclisa Escena marks a breakthrough in cancer treatment with its innovative delivery system.

Sarah Chen • Jul 17, 2026
Pharmaceutical

Merck's Lipfendra: A Game Changer in Cholesterol Treatment

Merck's Lipfendra gains FDA approval, positioning the company for significant growth in cholesterol treatment.

James McAllister • Jul 17, 2026
Markets & Money

US Import Prices Surprise Higher: What It Means for Inflation

June import prices in the US rose 0.3%, defying expectations, highlighting persistent inflation pressures.

Catherine Walsh • Jul 17, 2026
Markets & Money

Surge in US Housing Starts: A Promising Indicator for the Economy

US housing starts jumped 19% in June, signaling a robust economic outlook and potential shifts in Federal Reserve policy…

Tyler Brooks • Jul 17, 2026
Markets & Money

Fifth Third Bancorp: Positive Q2 Results Driven by Comerica Acquisition

Fifth Third Bancorp sees a boost in Q2 results following its acquisition of Comerica, indicating potential shifts in the…

Diana Kowalski • Jul 17, 2026